- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Atopic Dermatitis: One Patient's Experience With Instructions Regarding Use of Dupilumab
Elizabeth Acuna: The instructions and advice that I’ve been given regarding dupilumab, and the treatment schedule, have been really great. Obviously, it’s through the study protocol. So, I’ve been given some great advice about how to inject the medicine—following which areas to inject, which sites, and how to rotate that around. On top of that, calling in adverse reactions if I have anything. I make sure I call those in. The third thing is a weekly log, so I call in and report how I’m feeling. It’s a scale, 1-10, on certain things like how I’m feeling this week compared to other weeks. It really keeps a nice pulse on things. I definitely have some good follow-up and instructions where I feel very safe and very comfortable with the medication.
Reducing Time Sitting Can Help Lower BP in Older Adults, Randomized Trial Finds
April 20th 2024The randomized trial found that reducing sitting time over a 6-month period was association with reduced systolic blood pressure (BP) among a group of older patients with obesity and high rates of hypertension.
Read More
Early Involvement Critical in Treating Immunotherapy-Induced Overlap Syndrome
April 19th 2024A series of case studies reveals the importance of early diagnosis and involvement of special teams of clinicians when dealing with potential cases of overlap syndrome, which encompasses myocarditis, myasthenia gravis, and immune checkpoint inhibitor–related myositis.
Read More
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
